Journal article
Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary
Abstract
Persons with inflammatory bowel disease (IBD) make up more than 0.75% of the Canadian population in 2021. Early in the COVID-19 pandemic, individuals with IBD, particularly those on immunosuppressive therapies, were concerned that their health status may place them at higher risk of contracting COVID-19 or experiencing more severe disease course if infected with SARS-CoV-2. In response, Crohn's and Colitis Canada developed the COVID-19 and IBD …
Authors
Kuenzig ME; Windsor JW; Barrett L; Bernstein CN; Bitton A; Carroll MW; Chauhan U; Coward S; Fowler S; Ghia J-E
Journal
Journal of the Canadian Association of Gastroenterology, Vol. 4, No. Supplement_2, pp. s1–s9
Publisher
Oxford University Press (OUP)
Publication Date
November 5, 2021
DOI
10.1093/jcag/gwab027
ISSN
2515-2084